EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Clinical evaluation of paraprobiotic‐associated Bifidobacterium lactis CCT 7858 anti‐dandruff shampoo efficacy : A randomized placebo‐controlled clinical trial

Gabriel Fernandes Alves de Jesus, Marina Piola Rossetto, Ana Voytena, Bianca Feder, Heloisa Borges, Gabriel da Costa Borges, Zoé Paulina Feuser, Silvia Dal-Bó, Monique Michels iD

International Journal of Cosmetic Science · 2023

DOI: 10.1111/ics.12850 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Cosmetic Science, 2023. Verfasst von Gabriel Fernandes Alves de Jesus und 8 weiteren Autor:innen. Beteiligte Einrichtung: BioHall Consultoria, Pesquisa e Inovação, Itajai, Santa Catarina, Brazil. Hauptthemen laut MEDLINE: Dandruff, Bifidobacterium animalis, Hair Preparations. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: GABBIA, UNESC, Universidade do Extremo Sul Catarinense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The microbiome plays an important role in a wide variety of skin disorders. Hence, dysbiosis in the skin and/or gut microbiome is associated with an altered immune response, promoting the development of skin diseases, such as atopic dermatitis, psoriasis, acne vulgaris and dandruff. Studies have shown that paraprobiotics may be promising for the treatment of skin disorders through microbiota modulation and immunomodulation. So, the objective is to develop an anti‐dandruff formulation using a paraprobiotic (Neoimuno) as active ingredient.

Methods

Randomized, double‐blind, placebo‐controlled clinical trial was performed in patients who had any degree of dandruff. A total of 33 volunteers were recruited and randomly divided into two groups: placebo or treated. (1% Neoimuno). The ingredient used was Neoimuno ( Bifidobacterium lactis strain CCT 7858). Combability analysis and perception questionnaire were applied before and after treatment. Statistical analyses were performed.

Results

No adverse effects were reported by patients throughout the study. Through the combability analysis, a significant decrease in the number of particles was verified after 28 days of shampoo use. Regarding perception, there was a significant difference for the cleaning variables and improvement of the general appearance 28 days after the intervention. There were no significant differences for the itching and scaling parameters, as well as the perception parameters at 14 days.

Discussion

Topical application of the paraprobiotic shampoo containing 1% Neoimuno was able to significantly improve the feeling of cleanliness and general aspects of dandruff, in addition to reducing scalp flakiness. Thus, with the results obtained through the clinical trial, Neoimuno presents itself as a natural, safe and effective ingredient in the treatment of dandruff. The efficacy of Neoimuno in dandruff was visible within 4 weeks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DandruffBifidobacterium animalisHair PreparationsHumansScalpSkinPruritus

Stichwörter der Autor:innen

dandruffformulation/stabilityhair treatmentinactive probioticskin barrier

Substanzen

Hair Preparations

Autor:innen und Institutionen

  • BioHall Consultoria, Pesquisa e Inovação, Itajai, Santa Catarina, Brazil.
  • Gabbia Biotechnology, Itajai, Santa Catarina, Brazil.
  • Undergraduate Pharmacy Course, University of Southern Santa Catarina (UNESC), Criciuma, Brazil.
  • Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciuma, Brazil.

ORCID-Profile: Monique Michels

Förderung

  • GABBIA
  • UNESC
  • Universidade do Extremo Sul Catarinense

Zitieren

APA

de Jesus, G. F. A., Rossetto, M. P., Voytena, A., Feder, B., Borges, H., da Costa Borges, G., Feuser, Z. P., Dal-Bó, S., & Michels, M. (2023). Clinical evaluation of paraprobiotic‐associated Bifidobacterium lactis CCT 7858 anti‐dandruff shampoo efficacy : A randomized placebo‐controlled clinical trial. International Journal of Cosmetic Science. https://doi.org/10.1111/ics.12850

Vancouver

de Jesus GFA, Rossetto MP, Voytena A, Feder B, Borges H, da Costa Borges G, et al. Clinical evaluation of paraprobiotic‐associated Bifidobacterium lactis CCT 7858 anti‐dandruff shampoo efficacy : A randomized placebo‐controlled clinical trial. International Journal of Cosmetic Science. 2023. doi:10.1111/ics.12850

BibTeX
@article{deJesus2023,
  author = {de Jesus, Gabriel Fernandes Alves and Rossetto, Marina Piola and Voytena, Ana and Feder, Bianca and Borges, Heloisa and da Costa Borges, Gabriel and Feuser, Zoé Paulina and Dal-Bó, Silvia and Michels, Monique},
  title = {Clinical evaluation of paraprobiotic‐associated Bifidobacterium lactis CCT 7858 anti‐dandruff shampoo efficacy : A randomized placebo‐controlled clinical trial},
  journal = {International Journal of Cosmetic Science},
  year = {2023},
  doi = {10.1111/ics.12850}
}
Kostenlos starten →